Larry F Ellison1, Kathryn Wilkins. 1. Health Statistics Division, Statistics Canada, Ottawa, ON. larry.ellison@statcan.gc.ca
Abstract
BACKGROUND: The rising numbers of cancer diagnoses, together with improvements in survival, have led to increases in the prevalence of cancer in Canada. This article provides more precise and detailed estimates of cancer prevalence than have been available previously. DATA AND METHODS: Based on incidence data from the Canadian Cancer Registry linked with mortality data from the Canadian Vital Statistics Death Database, direct estimates of cancer prevalence as of January 1, 2005 were calculated for an extensive list of cancers, by time since diagnosis, age and sex. RESULTS: Two-, five- and ten-year cancer prevalence counts were 217,089 (675 per 100,000), 454,149 (1,412 per 100,000) and 722,833 (2,248 per 100,000), respectively. Breast (20.6% of ten-year prevalent cases), prostate (18.7%) and colorectal cancer (12.9%) were the most prevalent, together accounting for just over half of all cases. Prevalence proportions for all cancers combined increased dramatically with age, peaking at ages 80 to 84; proportions were higher in females than in males before age 60, and higher in males thereafter. INTERPRETATION: Prevalence data tabulated according to type of cancer, age and time since diagnoses provide important information about the demand for cancer-related health care and social services.
BACKGROUND: The rising numbers of cancer diagnoses, together with improvements in survival, have led to increases in the prevalence of cancer in Canada. This article provides more precise and detailed estimates of cancer prevalence than have been available previously. DATA AND METHODS: Based on incidence data from the Canadian Cancer Registry linked with mortality data from the Canadian Vital Statistics Death Database, direct estimates of cancer prevalence as of January 1, 2005 were calculated for an extensive list of cancers, by time since diagnosis, age and sex. RESULTS: Two-, five- and ten-year cancer prevalence counts were 217,089 (675 per 100,000), 454,149 (1,412 per 100,000) and 722,833 (2,248 per 100,000), respectively. Breast (20.6% of ten-year prevalent cases), prostate (18.7%) and colorectal cancer (12.9%) were the most prevalent, together accounting for just over half of all cases. Prevalence proportions for all cancers combined increased dramatically with age, peaking at ages 80 to 84; proportions were higher in females than in males before age 60, and higher in males thereafter. INTERPRETATION: Prevalence data tabulated according to type of cancer, age and time since diagnoses provide important information about the demand for cancer-related health care and social services.
Authors: Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell Journal: J Cancer Surviv Date: 2015-04-16 Impact factor: 4.442
Authors: Murilo A Luz; Ahmed F Kotb; Saad Aldousari; Fadi Brimo; Simon Tanguay; Wassim Kassouf; Armen G Aprikian Journal: World J Surg Oncol Date: 2010-11-09 Impact factor: 2.754
Authors: I Rachinsky; M Rajaraman; W D Leslie; A Zahedi; C Jefford; A McGibbon; J E M Young; K A Pathak; M Badreddine; S De Brabandere; H Fong; S Van Uum Journal: J Thyroid Res Date: 2016-11-29
Authors: Bertrand De Meulder; Fabrice Berger; Eric Bareke; Sophie Depiereux; Carine Michiels; Eric Depiereux Journal: PLoS One Date: 2014-01-31 Impact factor: 3.240